74 results on '"Hershberger, Ray E."'
Search Results
2. Consideration of disease penetrance in the selection of secondary findings gene-disease pairs: A policy statement of the American College of Medical Genetics and Genomics (ACMG)
3. The DCM Project Portal: A direct-to-participant platform of The DCM Research Project
4. ACMG SF v3.2 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG)
5. TTR variants in patients with dilated cardiomyopathy: An investigation of the DCM Precision Medicine Study
6. ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG)
7. Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2021 update: a policy statement of the American College of Medical Genetics and Genomics (ACMG)
8. Harmonizing the Collection of Clinical Data on Genetic Testing Requisition Forms to Enhance Variant Interpretation in Hypertrophic Cardiomyopathy (HCM): A Study from the ClinGen Cardiomyopathy Variant Curation Expert Panel
9. Familial Dilated Cardiomyopathy
10. Development of Clinical Domain Working Groups for the Clinical Genome Resource (ClinGen): lessons learned and plans for the future
11. Genetic evaluation of cardiomyopathy: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG)
12. Genetic Evaluation of Cardiomyopathy—A Heart Failure Society of America Practice Guideline
13. The Rationale and Timing of Molecular Genetic Testing for Dilated Cardiomyopathy
14. Heart Failure in Non-Caucasians, Women, and Older Adults: A White Paper on Special Populations From the Heart Failure Society of America Guideline Committee
15. Advanced (Stage D) Heart Failure: A Statement From the Heart Failure Society of America Guidelines Committee
16. Acute Decompensated Heart Failure: Update on New and Emerging Evidence and Directions for Future Research
17. Temporal Relationship of Conduction System Disease and Ventricular Dysfunction in LMNA Cardiomyopathy
18. Update on Aldosterone Antagonists Use in Heart Failure With Reduced Left Ventricular Ejection Fraction Heart Failure Society of America Guidelines Committee
19. Indications for Cardiac Resynchronization Therapy: 2011 Update From the Heart Failure Society of America Guideline Committee
20. 52 - The Dilated, Restrictive, and Infiltrative Cardiomyopathies
21. Functional Characterization of TNNC1 Rare Variants Identified in Dilated Cardiomyopathy
22. HRS/EHRA Expert Consensus Statement on the State of Genetic Testing for the Channelopathies and Cardiomyopathies: This document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA)
23. Rare variant mutations identified in pediatric patients with dilated cardiomyopathy
24. Genome-wide Studies of Copy Number Variation and Exome Sequencing Identify Rare Variants in BAG3 as a Cause of Dilated Cardiomyopathy
25. Colaboradores
26. 52 - Miocardiopatías dilatada, restrictiva e infiltrante
27. Clinical and genetic issues in dilated cardiomyopathy: A review for genetics professionals
28. Correction to: ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG)
29. Lamin A/C mutation analysis in a cohort of 324 unrelated patients with idiopathic or familial dilated cardiomyopathy
30. Transcriptomics and Beyond in Dilated Cardiomyopathy
31. Mutations of Presenilin Genes in Dilated Cardiomyopathy and Heart Failure
32. Clinical Characteristics of 304 Kindreds Evaluated for Familial Dilated Cardiomyopathy
33. Correction: Genetic evaluation of cardiomyopathy: a clinical practice resource of the American College of Medical Genetics and Genomics(ACMG)
34. 77 - The Dilated, Restrictive, and Infiltrative Cardiomyopathies
35. Prospective Evaluation of an Outpatient Heart Failure Disease Management Program Designed for Primary Care: The Oregon Model
36. Familial dilated cardiomyopathy
37. Consensus statement: palliative and supportive care in advanced heart failure
38. ACMG SF v3.1 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG)
39. Pilot Randomized Controlled Trial to Reduce Readmission for Heart Failure Using Novel Tablet and Nurse Practitioner Education
40. 65 - Cardiomiopatias Dilatada, Restritiva e Infiltrativa
41. Care processes and clinical outcomes of continuous outpatient support with inotropes (COSI) in patients with refractory endstage heart failure
42. Phenotypic And Genetic Profile Of Scn5a Variants In Idiopathic Dilated Cardiomyopathy
43. Response to McGurk et al
44. Contributors
45. A novel lamin A/C mutation in a family with dilated cardiomyopathy, prominent conduction system disease, and need for permanent pacemaker implantation
46. Cardiac troponin T lysine 210 deletion in a family with dilated cardiomyopathy
47. Pre-operative renal function predicts development of chronic renal insufficiency after orthotopic heart transplantation
48. Novel lamin A/C mutations in two families with dilated cardiomyopathy and conduction system disease
49. Prospective evaluation of an outpatient heart failure management program
50. Distribution and declines in cardiac allograft radionuclide left ventricular ejection fractions in relation to late mortality
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.